SALTEROL 250 ROTACAP

Product Description

SALTEROL 250 ROTACAP is a premium combination therapy designed for effective management of asthma and chronic obstructive pulmonary disease (COPD). Each rotacap contains Salmeterol 50mcg, a long-acting bronchodilator, and Fluticasone Propionate 250mcg, a potent corticosteroid offering dual-action respiratory relief by opening airways and reducing inflammation.

Manufactured in a GMP-certified facility, SALTEROL 250 ROTACAP is ideal for pharmaceutical distributors, hospital suppliers, and retail pharmacies seeking a reliable respiratory care solution. Its rotacap format ensures efficient pulmonary delivery and enhanced patient compliance.

Key Benefits:

• Dual-action formula for long-lasting asthma and COPD control

• Promotes bronchodilation and reduces airway inflammation

• Designed for rotahaler use convenient and effective inhalation delivery

• Ideal for chronic respiratory care in both acute and maintenance settings

Applications:

• Indicated in moderate to severe asthma treatment

• Recommended for maintenance therapy in COPD patients

• Widely prescribed by pulmonologists and respiratory specialists

Why Choose SALTEROL 250 ROTACAP?

• Backed by proven clinical efficacy

• Trusted by leading healthcare professionals and institutions

• Ready for bulk supply, third-party manufacturing, and export

• Attractive margins and fast-moving product in respiratory segment